Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Horowitz

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|November 20, 2009
When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypesLinda R Duska, Leslie Garrett, Melissa Henretta, et al.
Gynecologic Oncology|December 4, 2018
The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinomaThing Rinda Soong, Brooke E Howitt, Neil Horowitz, et al.
Gynecologic Oncology|September 5, 2006
Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopyMarcela G del Carmen, Molly Findley, Alona Muzikansky, et al.
Journal of Psychosocial Oncology|July 4, 2012
Young women diagnosed with early-stage ovarian cancer or borderline malignancy of the ovary: a focus on fertility and sexual functionSusana M Campos, Suzanne Berlin, Ursula A Matulonis, et al.
Journal of Geriatric Oncology|December 21, 2024
The pervasive impact of frailty on ovarian cancer care and the role of prehabilitation: Qualitative perspectives of key stakeholdersStephanie Cham, Rachel A Pozzar, Neil Horowitz, et al.
Gynecologic Oncology|October 9, 2017
Intensive care admissions among ovarian cancer patients treated with primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgeryKristen Pepin, Amy Bregar, Michelle Davis, et al.
Anticancer Research|October 28, 2025
Focused Ultrasound-mediated Disruption of Plasma Protein Binding Enhances Chemotherapeutic Effects of Paclitaxel on Xenografted Ovarian Cancer in MiceSeung-Schik Yoo, Kathryn Banish, Abduelrahman Fahmi, et al.
Gynecologic Oncology|April 16, 2025
Trends in sentinel lymph node evaluation for vulvar melanoma in the United States from 2012 to 2018Stephanie Alimena, Hadley Reid, Alexandra Bercow, et al.
Gynecologic Oncology|July 27, 2015
Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancerHaider Mahdi, Allison Gockley, Katherine Esselen, et al.
Gynecologic Oncology|May 13, 2018
The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in MassachusettsMichelle Davis, Kyle Strickland, Sarah Rae Easter, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|November 20, 2009
When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypesLinda R Duska, Leslie Garrett, Melissa Henretta, et al.
Gynecologic Oncology|December 4, 2018
The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinomaThing Rinda Soong, Brooke E Howitt, Neil Horowitz, et al.
Gynecologic Oncology|September 5, 2006
Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopyMarcela G del Carmen, Molly Findley, Alona Muzikansky, et al.
Journal of Psychosocial Oncology|July 4, 2012
Young women diagnosed with early-stage ovarian cancer or borderline malignancy of the ovary: a focus on fertility and sexual functionSusana M Campos, Suzanne Berlin, Ursula A Matulonis, et al.
Journal of Geriatric Oncology|December 21, 2024
The pervasive impact of frailty on ovarian cancer care and the role of prehabilitation: Qualitative perspectives of key stakeholdersStephanie Cham, Rachel A Pozzar, Neil Horowitz, et al.
Gynecologic Oncology|October 9, 2017
Intensive care admissions among ovarian cancer patients treated with primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgeryKristen Pepin, Amy Bregar, Michelle Davis, et al.
Anticancer Research|October 28, 2025
Focused Ultrasound-mediated Disruption of Plasma Protein Binding Enhances Chemotherapeutic Effects of Paclitaxel on Xenografted Ovarian Cancer in MiceSeung-Schik Yoo, Kathryn Banish, Abduelrahman Fahmi, et al.
Gynecologic Oncology|April 16, 2025
Trends in sentinel lymph node evaluation for vulvar melanoma in the United States from 2012 to 2018Stephanie Alimena, Hadley Reid, Alexandra Bercow, et al.
Gynecologic Oncology|July 27, 2015
Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancerHaider Mahdi, Allison Gockley, Katherine Esselen, et al.
Gynecologic Oncology|May 13, 2018
The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in MassachusettsMichelle Davis, Kyle Strickland, Sarah Rae Easter, et al.
Pageof 7